Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 34, Issue 14, Pages 1041-1049
Publisher
Oxford University Press (OUP)
Online
2012-12-21
DOI
10.1093/eurheartj/ehs435
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
- (2013) Daniel E. Singer ANNALS OF INTERNAL MEDICINE
- Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable
- (2013) Stuart J. Connolly ANNALS OF INTERNAL MEDICINE
- Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial
- (2013) Jonas Oldgren ANNALS OF INTERNAL MEDICINE
- Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study
- (2012) Jonas Bjerring Olesen et al. AMERICAN JOURNAL OF MEDICINE
- Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
- (2012) Allan C. Skanes et al. CANADIAN JOURNAL OF CARDIOLOGY
- Antithrombotic Therapy for Atrial Fibrillation
- (2012) John J. You et al. CHEST
- Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation
- (2012) Ziad Hijazi et al. CIRCULATION
- Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation
- (2012) Leif Friberg et al. CIRCULATION
- Use of the CHA 2 DS 2 -VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation
- (2012) Deirdre A. Lane et al. CIRCULATION
- Stroke and Thromboembolism in Atrial Fibrillation
- (2012) Ron Pisters et al. CIRCULATION JOURNAL
- Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation
- (2012) Pilar Gallego et al. Circulation-Arrhythmia and Electrophysiology
- Assessing the Risk of Bleeding in Patients With Atrial Fibrillation
- (2012) Gregory Y. H. Lip et al. Circulation-Arrhythmia and Electrophysiology
- Reliable Identification of “Truly Low” Thromboembolic Risk in Patients Initially Diagnosed With “Lone” Atrial Fibrillation
- (2012) Tatjana S. Potpara et al. Circulation-Arrhythmia and Electrophysiology
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPACE
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
- (2012) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project
- (2012) Amitava Banerjee et al. EUROPEAN JOURNAL OF HEART FAILURE
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- New anticoagulant treatments to protect against stroke in atrial fibrillation
- (2012) Tatjana S Potpara et al. HEART
- Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation—The potential role beyond the CHA2DS2-VASc score
- (2012) Tze-Fan Chao et al. HEART RHYTHM
- Sex Differences in Stroke Risk Among Older Patients With Recently Diagnosed Atrial Fibrillation
- (2012) Cynthia A. Jackevicius JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes
- (2012) Raffaele De Caterina et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation
- (2012) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The ATRIA Risk Scheme to Predict Warfarin-Associated Hemorrhage
- (2012) Jonas B. Olesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation
- (2012) Stavros Apostolakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study
- (2012) A. P. MIKKELSEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial
- (2012) Renato D Lopes et al. LANCET
- Anticoagulants in atrial fibrillation patients with chronic kidney disease
- (2012) Robert G. Hart et al. Nature Reviews Nephrology
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
- (2012) Jonas Bjerring Olesen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral anticoagulation use by patients with atrial fibrillation in Germany
- (2012) Antje Groth et al. THROMBOSIS AND HAEMOSTASIS
- Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction
- (2012) Husam Qasim et al. THROMBOSIS AND HAEMOSTASIS
- The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation
- (2012) Heyder Omran et al. THROMBOSIS AND HAEMOSTASIS
- The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study
- (2012) Christian Torp-Pedersen et al. THROMBOSIS AND HAEMOSTASIS
- Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
- (2012) L. Friberg et al. BMJ-British Medical Journal
- Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
- (2012) L. H. Rasmussen et al. BMJ-British Medical Journal
- Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation—A nation wide database analysis
- (2011) Lian-Yu Lin et al. ATHEROSCLEROSIS
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter
- (2011) John A. Cairns et al. CANADIAN JOURNAL OF CARDIOLOGY
- Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation
- (2011) Jonas Bjerring Olesen et al. CHEST
- 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
- (2011) Valentin Fuster et al. CIRCULATION
- Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications
- (2011) Y-F Lau et al. JOURNAL OF HUMAN HYPERTENSION
- CHADS2 and CHA2DS2-VASc Scores in the Prediction of Clinical Outcomes in Patients With Atrial Fibrillation After Catheter Ablation
- (2011) Tze-Fan Chao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation
- (2011) Ricarda Marinigh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A New Risk Scheme to Predict Warfarin-Associated Hemorrhage
- (2011) Margaret C. Fang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stroke in atrial fibrillation: epidemiology and thromboprophylaxis
- (2011) G. Y. H. LIP JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
- (2011) J. B. OLESEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data
- (2011) Carl Heneghan et al. LANCET
- The role of aspirin for stroke prevention in atrial fibrillation
- (2011) Gregory Y. H. Lip Nature Reviews Cardiology
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models
- (2011) Michael J. Pencina et al. STATISTICS IN MEDICINE
- Improving Stroke Risk Stratification Using the CHADS 2 and CHA 2 DS 2 -VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring
- (2011) Giuseppe Boriani et al. STROKE
- Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting
- (2011) John Eikelboom et al. THROMBOSIS AND HAEMOSTASIS
- Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe
- (2011) K. Airaksinen et al. THROMBOSIS AND HAEMOSTASIS
- Ischaemic cardiovascular mortality in patients with non-valvular atrial fibrillation according to CHADS2 score
- (2011) Young Dae Kim et al. THROMBOSIS AND HAEMOSTASIS
- Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options
- (2011) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
- (2011) Arlene Gallagher et al. THROMBOSIS AND HAEMOSTASIS
- Bleeding risk assessment and management in atrial fibrillation patients
- (2011) Laurent Fauchier et al. THROMBOSIS AND HAEMOSTASIS
- Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study
- (2011) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke
- (2011) Emma Wallace et al. THROMBOSIS AND HAEMOSTASIS
- Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
- (2011) Amitava Banerjee et al. THROMBOSIS AND HAEMOSTASIS
- Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
- (2010) Isla M. Ogilvie et al. AMERICAN JOURNAL OF MEDICINE
- Improving Stroke Risk Stratification in Atrial Fibrillation
- (2010) Gregory Y.H. Lip et al. AMERICAN JOURNAL OF MEDICINE
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Moving the Tipping Point
- (2010) Mark H. Eckman et al.
- Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk
- (2010) G. Y. H. Lip EUROPACE
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension
- (2010) L Y Ho et al. JOURNAL OF HUMAN HYPERTENSION
- Evidence That D-Dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients With Atrial Fibrillation During Oral Anticoagulant Therapy
- (2010) Tsuneaki Sadanaga et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice
- (2010) T. P. VAN STAA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
- (2010) Lars Wallentin et al. LANCET
- Identifying Patients at High Risk for Stroke Despite Anticoagulation
- (2010) Gregory Y.H. Lip et al. STROKE
- A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care
- (2010) Alessandro Filippi et al. THROMBOSIS AND HAEMOSTASIS
- New-onset atrial fibrillation and warfarin initiation: High risk periods and implications for new antithrombotic drugs
- (2010) Renato D. Lopes et al. THROMBOSIS AND HAEMOSTASIS
- New oral anticoagulant drugs in cardiovascular disease
- (2010) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1
- (2010) Laurent Gorin et al. THROMBOSIS AND HAEMOSTASIS
- The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?
- (2010) John W. Eikelboom et al. THROMBOSIS AND HAEMOSTASIS
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation
- (2009) Alan S. Go et al. CIRCULATION
- The Effect and Safety of the Antithrombotic Therapies in Patients with Atrial Fibrillation and CHADS2Score 1
- (2009) BYUNG HO LEE et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Cerebral Microbleeds Are Uncommon in Ischemic Stroke Associated with Nonvalvular Atrial Fibrillation
- (2009) Anastasios Chatzikonstantinou et al. JOURNAL OF NEUROIMAGING
- Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
- (2009) Timothy Watson et al. LANCET
- Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation
- (2009) Carl van Walraven et al. STROKE
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
- (2009) G. Y. H. Lip et al. THROMBOSIS AND HAEMOSTASIS
- Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme
- (2008) Stephan Rietbrock et al. AMERICAN HEART JOURNAL
- Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation
- (2008) Yi Wan et al.
- Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation
- (2008) Margaret C. Fang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk
- (2008) Jeff S. Healey et al. STROKE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started